Should aspirin be routinely used in patients with isolated dilated cardiomyopathy (DCM) without other indications such as coronary artery disease or prior myocardial infarction?

Aspirin in Dilated Cardiomyopathy (DCM)

Aspirin is NOT recommended for routine use in patients with isolated dilated cardiomyopathy without other indications such as coronary artery disease, prior myocardial infarction, or atrial fibrillation. 1

Clear Guideline Position

The 2006 Canadian Cardiovascular Society consensus explicitly states that "ASA is not required for patients with an idiopathic dilated cardiomyopathy and no other indication for ASA" 1. This represents the most direct guideline recommendation addressing your specific question.

When Aspirin IS Indicated in Heart Failure/DCM

Aspirin should only be used in DCM patients when there is a clear secondary prevention indication 1:

• Documented coronary artery disease - aspirin 75-100 mg daily is recommended lifelong 2
• Prior myocardial infarction - aspirin 75-162 mg daily unless contraindicated 3
• Atrial fibrillation requiring anticoagulation - low-dose aspirin (75-81 mg) may be added to warfarin in specific circumstances 3
• Peripheral artery disease - aspirin 75-325 mg daily 3

If aspirin is used, doses between 81-325 mg are appropriate, with lower doses (81 mg) preferred to minimize gastrointestinal bleeding risk 1.

Evidence Against Routine Aspirin in DCM

Multiple lines of evidence argue against routine aspirin use in isolated DCM:

Lack of proven benefit: Research reviews consistently show that current data do not support routine antiplatelet therapy for ambulatory heart failure patients without atrial fibrillation or coronary disease, as bleeding risk outweighs potential thromboembolic benefit 4. A critical literature review found insufficient data to recommend aspirin prophylaxis in chronic heart failure with left ventricular dilation absent additional indications 5.

Potential harm: Aspirin may actually worsen heart failure outcomes. Studies suggest aspirin is associated with more frequent hospitalizations for worsening heart failure, possibly through prostaglandin inhibition causing adverse hemodynamic and renal effects 6. High-dose aspirin shares risks with NSAIDs and may aggravate heart failure, especially in unstable patients 1.

Alternative Antiplatelet Agent

Clopidogrel 75 mg daily is the recommended alternative if aspirin is indicated but not tolerated due to allergy or intolerance 3, 2.

Critical Pitfalls to Avoid

• Do not prescribe aspirin reflexively in DCM patients simply because they have heart failure or reduced ejection fraction
• Do not use combination antiplatelet and anticoagulant therapy routinely (Class III recommendation) except for specific indications like acute coronary syndromes 1
• Avoid high-dose aspirin (>325 mg) as it increases bleeding and heart failure exacerbation risk 1
• Reassess need for aspirin if initially prescribed for coronary disease but patient is now remote from the acute event and has refractory heart failure 6

Clinical Algorithm

1. Identify the etiology of DCM: Is there underlying coronary disease, prior MI, or other atherosclerotic disease?

   • YES → Aspirin 75-100 mg daily is indicated 2
   • NO → Proceed to step 2

2. Check for atrial fibrillation or documented intracardiac thrombus:

   • YES → Anticoagulation (preferably NOAC) is indicated, not aspirin 1
   • NO → Proceed to step 3

3. Isolated DCM without coronary disease, prior MI, or AF:

   • Do NOT prescribe aspirin 1
   • Focus on guideline-directed medical therapy (ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists, SGLT2 inhibitors) 3